Ginkgo Bioworks Holdings, Inc.
DNA· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $66.40M | $77.61M | $13.30M |
| Net Income | -$670.13M | -$101.88M | -$26.06M |
| EPS Diluted | -$0.41 | -$0.08 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ginkgo Bioworks Holdings, Inc. · CIK 1830214 · Engraved from SEC EDGAR